Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04229056 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

COMPuter-assisted Self-training to Improve EXecutive Function

Study acronym: COMPEX
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 10 months later Dec 31, 2025 → Nov 5, 2026
See other at-risk trials from Bispebjerg Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 31, 2025 to Nov 5, 2026 Show 7 more changesShow less
    • Enrollment closed, study ongoing
    • Study completion pushed from Jun 30, 2026 to Feb 5, 2027
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: details revised at 23 of 27 entries
    • Site details revised at 2 of 2 sites
    • Collaborators revised (8)
    • Publications: details revised at 1 of 1 entry
  2. Enrollment target: 700 to 307v7 Show 6 more changesShow less
    • Primary completion date: Jun 28, 2024 to Dec 31, 2025
    • Primary endpoints: 2 to 1
    • Study completion date: Dec 31, 2024 to Jun 30, 2026
    • Secondary endpoints: 26 to 27
    • Study description shortened, about 12 words
    • Collaborators: 6 to 8
  3. Enrollment target: 600 to 700
    • Eligibility criteria revised
    • Secondary endpoints revised (26)
    v6
  4. Eligibility criteria shortened, about 15 wordsv5 Show 4 more changesShow less
    • Secondary endpoints: details revised at 26 of 26 entries
    • Study description expanded, about 23 words
    • Site details revised at 1 of 2 sites
    • Collaborators: 3 to 6
  5. Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary endpoints revised (2)
    • Secondary endpoints revised (26)
    v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Enrollment target: 300 to 600
    • Primary endpoints: 1 to 2
    • Study sites: 0 to 2
    • Start date changed from estimate of Oct 1, 2020 to Jun 1, 2020
    • Secondary endpoints: 27 to 26
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Bispebjerg Hospital
48 trials monitored
See 2 trials at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Stroke
3,531 trials monitored
See 153 trials at risk
Parkinson's Disease
1,459 trials monitored
See 68 trials at risk
This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to generally cognitively stimulating activities on a computer
Trial Details
NCT Number NCT04229056
Lead Sponsor Bispebjerg Hospital
Collaborators: Copenhagen University Hospital, Rigshospitalet, University of Glasgow, University of Basel, Copenhagen Trial Unit, Center for Clinical Intervention Research, Hjernesagen, Göteborg University, Aalborg University Hospital, Neurorehabilitering - Kbh, City of Copenhagen
Conditions
(from sponsor)		 Parkinson Disease, Stroke, Cardiac Arrest, Cognitive Dysfunction, Executive Dysfunction
Related terms Cognitive Dysfunction, Heart Arrest, Parkinson Disease, Stroke
Enrollment 307 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov